» Articles » PMID: 17306896

The C-jun Kinase/stress-activated Pathway: Regulation, Function and Role in Human Disease

Overview
Specialties Biochemistry
Biophysics
Date 2007 Feb 20
PMID 17306896
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

c-Jun N-terminal kinases (JNKs), also referred to as stress-activated kinases (SAPKs), were initially characterized by their activation in response to cell stress such as UV irradiation. JNK/SAPKs have since been characterized to be involved in proliferation, apoptosis, motility, metabolism and DNA repair. Dysregulated JNK signaling is now believed to contribute to many diseases involving neurodegeneration, chronic inflammation, birth defects, cancer and ischemia/reperfusion injury. In this review, we present our current understanding of JNK regulation and their involvement in homeostasis and dysregulation in human disease.

Citing Articles

Nitroxidative Stress, Cell-Signaling Pathways, and Manganese Porphyrins: Therapeutic Potential in Neuropathic Pain.

Silva A, de Lavor M Int J Mol Sci. 2025; 26(5).

PMID: 40076672 PMC: 11900433. DOI: 10.3390/ijms26052050.


The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies.

Liu S, Zhang G, Li N, Wang Z, Lu L J Inflamm Res. 2025; 18:1951-1967.

PMID: 39959642 PMC: 11829118. DOI: 10.2147/JIR.S489613.


Effects of Korean red ginseng on auditory, cognitive, and liver functions in a naturally aged mouse model.

Shin S, Shim J, Nam Y, Kim N, Seo G, Nevedita M J Ginseng Res. 2025; 49(1):71-79.

PMID: 39872287 PMC: 11764134. DOI: 10.1016/j.jgr.2024.10.001.


The functional roles of competitive endogenous RNA (ceRNA) networks in apoptosis in human cancers: The circRNA/miRNA/mRNA regulatory axis and cell signaling pathways.

Shahpari M, Hashemi M, Younesirad T, Hasanzadeh A, Mosanne M, Ahmadifard M Heliyon. 2024; 10(21):e37089.

PMID: 39524849 PMC: 11546195. DOI: 10.1016/j.heliyon.2024.e37089.


Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads.

Balint D, Poti A, Alexa A, Sok P, Albert K, Torda L Nat Commun. 2024; 15(1):8606.

PMID: 39366946 PMC: 11452492. DOI: 10.1038/s41467-024-52573-2.


References
1.
Ferrandi C, Ballerio R, Gaillard P, Giachetti C, Carboni S, Vitte P . Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol. 2004; 142(6):953-60. PMC: 1575119. DOI: 10.1038/sj.bjp.0705873. View

2.
Jaeschke A, Czech M, Davis R . An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes Dev. 2004; 18(16):1976-80. PMC: 514178. DOI: 10.1101/gad.1216504. View

3.
Zine A, Van De Water T . The MAPK/JNK signalling pathway offers potential therapeutic targets for the prevention of acquired deafness. Curr Drug Targets CNS Neurol Disord. 2004; 3(4):325-32. DOI: 10.2174/1568007043337166. View

4.
Resnick L, Fennell M . Targeting JNK3 for the treatment of neurodegenerative disorders. Drug Discov Today. 2004; 9(21):932-9. DOI: 10.1016/S1359-6446(04)03251-9. View

5.
Pulverer B, Kyriakis J, Avruch J, Nikolakaki E, Woodgett J . Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991; 353(6345):670-4. DOI: 10.1038/353670a0. View